Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,778 Jan 1 – Oct 27, 2026
- Disclosed funding
- $349.4B 3714 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Y Provides AI-powered credit card products for consumers | $200M | Undisclosed | Fintech | United States | Investors | |
| P Provides end-to-end technology platform for independent food distributors | $50M | Series CSeries C+ | Foodtech | United States | Investors | |
| PT Produces rare earth metals and alloys for global customers | $40.2M | Series B3Series B | Climate tech | United States | Investors | |
| EW Eagle WirelessCompany profile Provides cellular modules and full-device solutions for IoT and automotive industries Provides cellular modules and full-device solutions for IoT and automotive industries | $30M | Series B | Hardware | United States | Investors | |
| C Develops real-time compliance infrastructure for regulated financial services | €6M | Series A | Fintech | Lithuania | Investors | |
| CM Code MetalCompany profile Provides verifiable code translation and optimization for AI and legacy code across platforms Provides verifiable code translation and optimization for AI and legacy code across platforms | $125M | Series B | Defense tech | United States | Investors | |
| TT Ten63 TherapeuticsCompany profile Develops AI-driven drug discovery platform for first- and best-in-class therapeutics Develops AI-driven drug discovery platform for first- and best-in-class therapeutics | $45M | StrategicUndisclosed | AI | United States | Investors | |
| T AI-powered repair platform for fashion and electronics | €1.5M | Seed | AI | Lithuania | Investors | |
| i Provides financing and dining rewards for restaurants and consumers | $450M | Growth | Foodtech | United States | Investors | |
Altesa BioSciencesCompany profile Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. | $75M | Series B | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
162rounds5led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
113rounds22led - 3General Catalyst
Hyperbolic, Re:Build, Matiks
105rounds14led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Hex, Nevis, Warhound
74rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →